Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review

Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review

IntroductionPrader-Willi syndrome (PWS) is the most prevalent cause of syndromic obesity. Obesity development in PWS is driven by dysfunction in neural pathways involved in satiety and reward, dysregulation in hormones regulating satiety and food intake, altered body composition and reduced energy e...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrijana Koceva, Katarina Mlekuš Kozamernik, Andrej Janež, Rok Herman, Simona Ferjan, Mojca Jensterle
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Endocrinology
Subjects:
Prader-Willi syndrome
obesity
GLP-1 receptor agonist
semaglutide
metabolic surgery
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1528457/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items